Celldex Therapeutics, Inc. - Common Stock (CLDX)

Celldex Therapeutics is a biopharmaceutical company focused on the development of innovative immunotherapy products for the treatment of cancer and other serious diseases

The company specializes in creating targeted therapies that harness the body's immune system to fight cancer cells, with a portfolio that includes monoclonal antibodies, antibody-drug conjugates, and other novel biological agents. Celldex is dedicated to advancing its clinical trials and research programs, aiming to bring new treatment options to patients with unmet medical needs, particularly in oncology. Through its commitment to scientific excellence and patient care, Celldex seeks to transform the landscape of cancer treatment and improve the outcomes for those affected by these challenging conditions.